UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases

Raman, SR; Man, KKC; Bahmanyar, S; Berard, A; Bilder, S; Boukhris, T; Bushnell, G; ... Wong, ICK; + view all (2018) Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. The Lancet Psychiatry , 5 (10) pp. 824-835. 10.1016/S2215-0366(18)30293-1. Green open access

[thumbnail of Raman_Man_ADHD_medication_20180713.pdf]
Preview
Text
Raman_Man_ADHD_medication_20180713.pdf - Accepted Version
Available under License : See the attached licence file.

Download (812kB) | Preview
[thumbnail of Supplementary file 1] Text (Supplementary file 1)
Wong_Appendix_Table A1toA9_201807012.pdf - Accepted Version
Available under License : See the attached licence file.

Download (698kB)
[thumbnail of Supplementary file 2] Text (Supplementary file 2)
Wong_ADHD_trend_TABLES_20180711 (2).pdf - Accepted Version
Available under License : See the attached licence file.

Download (91kB)

Abstract

BACKGROUND: The use of medications to treat attention deficit hyperactivity disorder (ADHD) has increased, but the prevalence of ADHD medication use across different world regions is not known. Our objective was to determine regional and national prevalences of ADHD medication use in children and adults, with a specific focus on time trends in ADHD medication prevalence. METHODS: We did a retrospective, observational study using population-based databases from 13 countries and one Special Administrative Region (SAR): four in Asia and Australia, two in North America, five in northern Europe, and three in western Europe. We used a common protocol approach to define study populations and parameters similarly across countries and the SAR. Study populations consisted of all individuals aged 3 years or older between Jan 1, 2001, and Dec 31, 2015 (dependent on data availability). We estimated annual prevalence of ADHD medication use with 95% CI during the study period, by country and region and stratified by age and sex. We reported annual absolute and relative percentage changes to describe time trends. FINDINGS 154·5 million individuals were included in the study. ADHD medication use prevalence in 2010 (in children aged 3–18 years) varied between 0·27% and 6·69% in the countries and SAR assessed (0·95% in Asia and Australia, 4·48% in North America, 1·95% in northern Europe, and 0·70% in western Europe). The prevalence of ADHD medication use among children increased over time in all countries and regions, and the absolute increase per year ranged from 0·02% to 0·26%. Among adults aged 19 years or older, the prevalence of any ADHD medication use in 2010 varied between 0·003% and 1·48% (0·05% in Asia and Australia, 1·42% in North America, 0·47% in northern Europe, and 0·03% in western Europe). The absolute increase in ADHD medication use prevalence per year ranged from 0·0006% to 0·12%. Methylphenidate was the most commonly used ADHD medication in most countries. INTERPRETATION: Using a common protocol and data from 13 countries and one SAR, these results show increases over time but large variations in ADHD medication use in multiple regions. The recommendations of evidence-based guidelines need to be followed consistently in clinical practice. Further research is warranted to describe the safety and effectiveness of ADHD medication in the short and long term, and to inform evidence-based guidelines, particularly in adults.

Type: Article
Title: Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/S2215-0366(18)30293-1
Publisher version: https://doi.org/10.1016/S2215-0366(18)30293-1
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Practice and Policy
URI: https://discovery.ucl.ac.uk/id/eprint/10058682
Downloads since deposit
1,136Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item